Q: A recent New Yorker article described people who had taken these drugs and reported a side effect of less excitement about life
Acute pancreatitis In January 2026, the UK MHRA has instructed manufacturers to update the product information for all GLP-1 and dual GIP/GLP-1 receptor agonists to highlight the potential risk of severe acute pancreatitis associated with these drugs, including rare reports of necrotizing and fatal pancreatitis [13]
Research confirms this approach
The American Journal of Clinical Nutrition , 87(1), 155S158S
If you or a loved one suffered severe complications after taking Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus, or another GLP-1 medication, contact TorHoerman Law for a free case review to learn more about your legal options
[19] However, these effects result from gastric distension and increased fullness rather than hormonal changes in GLP-1 or other incretins